1. Physician Rewards for Postmarketing Surveillance (Seeding Studies) in the US

   • John La Puma

   Guest Editorial 17 November 2012 Pages: 187 - 190

2. Minimising the Cost of Urinary Incontinence in Nursing Homes

   • Judy Steel
   • David Fonda

   Leading Article 17 November 2012 Pages: 191 - 197

3. Economic Decision Making in Healthcare

   • Alan L. Hillman
   • Myoung S. Kim

   Leading Article 17 November 2012 Pages: 198 - 205

4. Relationships Between Sponsors and Investigators in Pharmacoeconomic and Clinical Research

   • Kevin A. Schulman
   • L. Elizabeth Rubenstein
   • John M. Eisenberg

   Review Article 17 November 2012 Pages: 206 - 220

5. Defining the Patient Group for Cost-Effective Withdrawal of Antihypertensive Therapy

   • Lawrence R. Krakoff
   • Sylvia Wassertheil-Smoller

   Review Article 17 November 2012 Pages: 221 - 228

6. Quality-of-Life Instruments for Severe Chronic Mental Illness

   • Marion Becker

   Review Article 17 November 2012 Pages: 229 - 237

7. Effect of Lenograstim on the Cost of Autologous Bone Marrow Transplantation

   • Pauline Brice
   • Sylvie Godin
   • Christian Gisselbrecht

   Original Research Article 17 November 2012 Pages: 238 - 241

8. The Cost Effectiveness of Hypertension Treatment in Sweden

   • Magnus Johannesson

   Original Research Article 17 November 2012 Pages: 242 - 250

9. Pharmacoeconomic Analysis of Topical Treatments for Tinea Infections

   • Neil H. Shear
   • Thomas R. Einarson
   • John J. Doyle

   Original Research Article 17 November 2012 Pages: 251 - 267

10. Alglucerase: The Debate Continues

    • Stephen Push
    • Alan M. Garber

    Correspondence 17 November 2012 Pages: 268 - 269